It’s unclear what will become of some of the rules and regulations advanced by the 2010 health law as Republicans in Congress work to dismantle the sweeping measure.
A Kaiser Health News analysis finds that the portion of federal marketplace plans requiring people to pay a third or more of the cost of specialty drugs have jumped from 37 to 63 percent since 2014. California has greater protections to limit consumer costs.
The Centers for Medicare & Medicaid Innovation was charged by the health law with exploring payment reforms that could cut health care costs and possibly improve quality. But its future is hinged to whether GOP lawmakers see value in its work.
Why an obscure revenue raiser for the Affordable Care Act has found its way into a number of congressional campaign ads.
Some major insurance companies are opting not to pay commissions for plans sold in the Affordable Care Act’s marketplaces, while others are cutting their commissions. Will this make enrollment season more difficult for consumers?
High-intensity focused ultrasound, often not covered by insurance, leads to discussions about which patients benefit in the real world.
The flu vaccine is available for longer windows of time. Experts say to weigh convenience and science in deciding when to roll up your sleeve.
The number of prescriptions for Medicare beneficiaries is on the rise, too.
Research shows exercise-based cardiac rehab programs help heart patients heal faster and live longer. But fewer than a third take part. Time and cost are the main barriers, doctors and patients say.
As news that Mylan will make available a generic version of its own brand-name product, KHN answers key questions about how this development could affect consumers.